TNF and obesity disorder: In consistent with obtained results regarding reduction of pre-inflammatory changes in obesity, suppressing an decreasing of TNF-α and IL-6 production in adipose tissue or serum [43–45, 47, 48], reducing IL-β1 [45, 50].